Some studies suggested that circulating betatrophin levels are elevated in type 2 diabetes and obesity [7–10], correlating with lipid profiles, while others reported that betatrophin is associated only with lipid metabolism and has nothing to do with glucose homeostasis [11, 12]. Here, ANGPTL8 is linked to obesity due to melanocortin 4 receptor deficiency.